The Harvard case of Xu Xiping: exploitation of the people, scientific advance, or genetic theft?
{{output}}
A unique history and make-up of a population may make it an attractive research target for population geneticists and pharmaco-genomic investors. The promise of pharmaceutical profits and advances in medical knowledge attracted Harvard researchers and the comp... ...
